ContractShare Sale Agreement • July 15th, 2024 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
ContractShare Sale Agreement • February 6th, 2023 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
ContractShare Sale Agreement • August 30th, 2022 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
ContractShare Sale Agreement • June 30th, 2022 • Gelteq LTD • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed